Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Sensor biochips could aid in cancer diagnosis and treatment

22.10.2009
Munich researchers develop new test process for cancer drugs

It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient.

Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs. With the help of microchips, they can establish in the laboratory whether a patient's tumor cells will react to a given drug. This chip could help in future with the rapid identification of the most effective medication for the individual patient.

Cancer is the second most common cause of death in the Western world. According to the German Cancer Research Center in Heidelberg, approximately 450,000 people develop cancer every year in Germany. Although the doctors who treat cancer have numerous cancer drugs at their disposal today, the treatment must be precisely tailored to the patient and the type of cancer in question to be as effective as possible. If it takes a second or third try to find a drug that works, the patient loses valuable time in which the tumor can continue to grow.

In the future, miniature laboratories could provide the fast help required here. A lab-on-a-chip is a device -- made of glass, for example -- that is just a few millimeters across and has bioelectronic sensors that monitor the vitality of living cells. The chips sit in small wells, known as microtiter plates, and are covered with a patient's tumor cells. A robot changes the culture fluid in each well containing a chip at intervals of just a few minutes. The microsensors on the chip record, among other things, changes in the acid content of the medium and the cells' oxygen consumption; photographs of the process are also taken by a microscope fitted underneath the microtiter plate. All of the data merge in a computer that is connected to the system, and which provides an overview of the metabolic activity of the tumor cells and their vitality.

The robots and microtiter plates are kept in a chamber which, through precisely regulated temperature and humidity, provides an environment similar to that of the human body, and which also protects the tumor cells against external influences that can falsify the test results.

After the tumor cells have been able to divide undisturbed for a few hours, the robot applies an anti-cancer substance. If their metabolic activity declines over the next day or two, the active substance was able to kill the tumor cells and the drug is effective. Using the microchips, twenty-four active substances or combinations of active substances can be tested simultaneously in this way.

The gain in time for the patient is not the only positive factor here. Dr. Helmut Grothe, a scientist from the Heinz Nixdorf Chair at the TUM, explains: "Treatment with an ineffective cancer drug sometimes leads to the development of resistance to other drugs in the patient." Such resistance on the part of the tumor cells can also be identified at an early stage with the help of the sensor chip.

Another advantage of the system is its automation. The robot works faster and more accurately than any human could. Hence, the test results can be obtained quickly, which, in turn, saves on costs. Furthermore, the possibility of testing tumor cells with several active substances simultaneously facilitates the search for effective substances for individually tailored cancer treatment. Pharmaceutical companies may also be able to use the sensor chip in the development of new drugs in future.

As part of another research project, the scientists at the Heinz Nixdorf Chair are also developing a sensor chip that is intended to control tumor growth. The chip, which would be implanted once in the vicinity of the tumor, could release cancer drugs or pain medication only when the tumor grows. The release of the active substances would be controlled by electrical impulses. This sensor system could be used in the treatment of inoperable tumors, for example pancreatic tumors.

In the past, microchips have also been developed at the TUM's Heinz Nixdorf Chair for use in other research fields. For example, one such system is used in the analysis of the water quality of streams and rivers. In this case, a small pump removes samples at regular intervals from the water body and channels it via a pipe to a sensor chip on which algae have been planted. As algae are highly sensitive to toxic substances, they are particularly suitable for water analysis and react to the minutest impurities: their metabolic activity, which is measured on the basis of their oxygen production, declines in less than one minute in the presence of toxins. The data recorded by this sensor system are transmitted via mobile telephone to a computer that raises the alarm. The TUM research team won the E.ON Environmental Award, presented by the Bavarian energy company of the same name, for this system in 2008.

Contact:
Dr.-Ing. Helmut Grothe
Head of Technology Development
Heinz-Nixdorf Chair for Medical Electronics
Technische Universitaet Muenchen
Tel: +49.89.289.22949
E-mail: grothe@tum.de

Markus Bernards | EurekAlert!
Further information:
http://portal.mytum.de

More articles from Life Sciences:

nachricht New technique unveils 'matrix' inside tissues and tumors
29.06.2017 | University of Copenhagen The Faculty of Health and Medical Sciences

nachricht Designed proteins to treat muscular dystrophy
29.06.2017 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making Waves

Computer scientists use wave packet theory to develop realistic, detailed water wave simulations in real time. Their results will be presented at this year’s SIGGRAPH conference.

Think about the last time you were at a lake, river, or the ocean. Remember the ripples of the water, the waves crashing against the rocks, the wake following...

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Nanostructures taste the rainbow

29.06.2017 | Physics and Astronomy

New technique unveils 'matrix' inside tissues and tumors

29.06.2017 | Life Sciences

Cystic fibrosis alters the structure of mucus in airways

29.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>